Keywords
How to Cite
Abstract
Ushbu tezisda yurak ishemik kasalligi (YIK) bilan og‘rigan bemorlarda gipolipidemik terapiyaning samaradorligi tahlil qilinadi. YIK va dislipidemiya o‘rtasidagi bog‘liqlik, gipolipidemik dori vositalarining ta’siri va bemorlardagi klinik ko‘rsatkichlar o‘rganiladi. Tadqiqotda statinlar va boshqa gipolipidemik preparatlar bilan davolashning kardiovaskulyar natijalarga ta’siri tahlil etiladi. Maqsad — gipolipidemik terapiyaning samaradorligini baholash va klinikada qo‘llash bo‘yicha tavsiyalar ishlab chiqish.
References
1. Sultonov A.X., “Yurak ishemik kasalligini davolashning zamonaviy usullari”, Tibbiyot nashriyoti, 2021 yil, 240 b.
2. Karimova M.R., “Gipolipidemik davo vositalari va ularning klinik samaradorligi”, Ilm va taraqqiyot, 2020 yil, 198 b.
3. Nazarov B.T., “Kardiologiyada farmakoterapiya asoslari”, Shifo Print, 2019 yil, 276 b.
4. Akhmedov U.I., “Yurak qon-tomir kasalliklarining oldini olishda lipid nazoratining o‘rni”, Tibbiyot fanlari markazi, 2022 yil, 210 b.
5. Шукурова, У. А., Садикова, И. Э., & Бахадиров, Р. Г. (2019). Современные методы лечения клиновидных дефектов твердых тканей зубов. In Актуальные проблемы стоматологии детского возраста и ортодонтии (pp. 212-216).
6. Shukurova, U. A., & Gaffarova, S. S. (2022). Indicators Of Free Radical Oxidation Of Oral Fluid In Patients With Lichen Plus Of The Mucosus Cavity Of The Mouth. Journal of Pharmaceutical Negative Results, 862-865.
7. Sunnatulloevna, G. S., Abdurasulovna, S. U., Amrulloevich, G. S., & FeruzaSaidkarimovna, M. Comparative Evaluation of Adhesive Microbial Colonization of the Oral Cavity to Various Filling Materials. International Journal on Integrated Education, 4(6), 235-241.
This work is licensed under a Creative Commons Attribution 4.0 International License.
